FTXHvsBMEDETF Comparison
VS
First Trust Nasdaq Pharmaceuticals ETF (FTXH) belongs to the US Health Care segment. iShares Health Innovation Active ETF (BMED) is part of the Healthcare Technology segment. FTXH's top 1 sector exposures are Healthcare. In contrast, BMED's top sector exposures are Healthcare and Non-Corporate. FTXH is less expensive with a Total Expense Ratio (TER) of 0.6%, versus 0.77% for BMED. FTXH is up 23.32% year-to-date (YTD) with +$978M in YTD flows. BMED performs worse with 8.9% YTD performance, and +$5M in YTD flows. Run a side-by-side ETF comparison of FTXH and BMED below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
FTXH vs BMED performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/10/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | FTXH BMED | +0.75%+1.70% | +14.81%+15.34% | +23.32%+8.90% | +46.70%+23.31% | +58.20%+38.64% | +66.91%+9.68% |
| Flows | FTXH BMED | +$41M+$1M | +$968M+$1M | +$978M+$5M | +$981M+$7M | +$973M+$7M | +$977M+$6M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | FTXH BMED | +20.07%+21.51% | +17.74%+17.49% | +16.99%+16.66% | +16.34%+18.04% |
| Max drawdown | FTXH BMED | -5.34%-5.85% | -7.50%-14.71% | -19.32%-19.76% | -19.32%-32.96% |
| Max drawdown duration | FTXH BMED | 16d17d | 99d196d | 393d237d | 393d1523d |
Trading data
FTXH | BMED | |
Last sale 9/11/2026 at 1:30 PM | $40.47 | $32.97 |
| Previous close 09/10/2026 | $40.52 | $32.80 |
| Consolidated volume 09/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
BMED
is actively managed and doesn’t replicate an indexFTXH | BMED | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/11/2026 at 1:30 PM
Live
Closed
FTXH | BMED | |
|---|---|---|
| Last price | $40.47 | $32.97 |
| 1D performance | -0.13% | +0.49% |
| AuM | $1.04 B | $13.16 M |
| E/R | 0.6% | 0.77% |
Characteristics
FTXH | BMED | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | First Trust | iShares |
| Benchmark | NASDAQ US Smart Pharmaceuticals Index | - |
| N° of holdings | 49 | 54 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | September 20, 2016 | September 29, 2020 |
| ESG | No | No |
Advertisement
Exposure
Countries
FTXH
USA
95.79%
Other
4.21%
BMED
USA
86.04%
Other
13.96%
Sectors
FTXH
Healthcare
99.86%
Other
0.14%
BMED
Healthcare
95.7%
Other
4.3%
Advertisement
Diversification
FTXH
Total weight of top 15 holdings out of 15
66.98%
BMED
Total weight of top 15 holdings out of 15
56.15%
Top 15 holdings
Data as of July 31, 2026
FTXH
Merck & Co., Inc.
7.58%
Eli Lilly & Co.
7.43%
AbbVie, Inc.
7.11%
Johnson & Johnson
6.78%
Bristol Myers Squibb Co.
6.61%
Amgen, Inc.
3.53%
Biogen, Inc.
3.52%
Vertex Pharmaceuticals, Inc.
3.43%
Viatris, Inc.
3.40%
Regeneron Pharmaceuticals, Inc.
3.34%
Pfizer Inc.
3.17%
Cardinal Health, Inc.
3.14%
Gilead Sciences, Inc.
3.03%
Incyte Corp.
2.48%
United Therapeutics Corp.
2.43%
BMED
Merck & Co., Inc.
5.85%
Gilead Sciences, Inc.
4.87%
Johnson & Johnson
4.45%
Edwards Lifesciences Corp.
4.43%
Thermo Fisher Scientific, Inc.
4.17%
Charles River Laboratories International, Inc.
3.72%
Danaher Corp.
3.63%
Biogen, Inc.
3.58%
Waters Corp.
3.50%
AbbVie, Inc.
3.50%
Mettler-Toledo International, Inc.
3.37%
Moderna, Inc.
3.07%
Vertex Pharmaceuticals, Inc.
2.96%
BlackRock Cash Funds - Treasury
2.58%
Amgen, Inc.
2.49%
Frequently asked questions about FTXH and BMED
How have the FTXH and BMED ETFs performed in 2026?
As of September 10, 2026, FTXH is up 23.32% year-to-date (YTD), while BMED has returned 8.9%. That puts FTXH better performer ahead so far this year.
Which ETF is attracting more investor money: FTXH or BMED?
Year-to-date, the FTXH ETF saw +$978M in flows, compared to +$5M for BMED.
Which ETF is more volatile: FTXH or BMED?
Over the past year, FTXH had a volatility of 17.74%, while BMED experienced 17.49%.
Which ETF is bigger: FTXH or BMED?
As of September 10, 2026, FTXH holds $1.04 B in assets under management (AUM), while BMED manages $13.16 M.
What sectors do the FTXH and BMED ETFs invest in?
FTXH leans toward sectors like Healthcare. Meanwhile, BMED focuses on Healthcare.
What are the top holdings of the FTXH ETF and BMED ETF?
FTXH top holdings include Merck & Co., Inc., Eli Lilly & Co. and AbbVie, Inc.. BMED holds in its top three: Merck & Co., Inc., Gilead Sciences, Inc. and Johnson & Johnson.
Which ETF is more diversified: FTXH or BMED?
FTXH holds 49 securities with 66.98% of its assets in the top 15. BMED has 56 securities and a top 15 weight of 56.15%.
Advertisement
Advertisement
